Get started
Lexeo Therapeutics, Inc.Lexeo Therapeutics, Inc.Lexeo Therapeutics, Inc.

Lexeo Therapeutics, Inc.

No trades
See on Supercharts
Overview
Financials News Ideas Technicals Forecast

LXEO chart

Upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats

Market capitalization
‪351.99 M‬USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−2.49USD
Net income (FY)
‪−66.39 M‬USD
Revenue (FY)
—
Shares float
‪16.04 M‬
Beta (1Y)
1.76

About Lexeo Therapeutics, Inc.

Sector
Health Technology
Industry
Biotechnology
CEO
R. Nolan Townsend
Website
lexeotx.com
Headquarters
New York
Employees (FY)
58
Founded
2017
FIGI
BBG00YB1C8M5
Lexeo Therapeutics, Inc. is a clinical stage genetic medicine company, which engages in the development of therapies for hereditary and acquired diseases. The firm focuses on the medication of genetically defined cardiovascular diseases and sub-group of Alzheimer’s disease. It offers LX2006 for the treatment of patients with Friedreich's ataxia, cardiomyopathy, and LX1001 for APOE4 homozygous patients with Alzheimer's disease. The company was founded by Ronald G. Crystal in February 2017 and is headquartered in New York, NY.

Financials

Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

News

Keep reading

Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating

An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Stock brokers

Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of LXEO is 13.06 USD — it has decreased by 1.14% in the past 24 hours. Watch Lexeo Therapeutics, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Lexeo Therapeutics, Inc. stocks are traded under the ticker LXEO.
Lexeo Therapeutics, Inc. is going to release the next earnings report on May 29, 2024. Keep track of upcoming events with our Earnings Calendar.
LXEO stock is 4.35% volatile and has beta coefficient of 1.76. Track Lexeo Therapeutics, Inc. stock price on the chart and check out the list of the most volatile stocks — is Lexeo Therapeutics, Inc. there?
LXEO earnings for the last quarter are −0.86 USD per share, whereas the estimation was −0.70 USD resulting in a −23.43% surprise. The estimated earnings for the next quarter are −0.74 USD per share. See more details about Lexeo Therapeutics, Inc. earnings.
Yes, you can track Lexeo Therapeutics, Inc. financials in yearly and quarterly reports right on TradingView.
LXEO stock has risen by 3.53% compared to the previous week, the month change is a 0.38% fall, over the last year Lexeo Therapeutics, Inc. has showed a 37.47% increase.
LXEO net income for the last quarter is ‪−14.19 M‬ USD, while the quarter before that showed ‪−20.11 M‬ USD of net income which accounts for 29.44% change. Track more Lexeo Therapeutics, Inc. financial stats to get the full picture.
Today Lexeo Therapeutics, Inc. has the market capitalization of ‪351.99 M‬, it has increased by 3.82% over the last week.
No, LXEO doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, LXEO shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Lexeo Therapeutics, Inc. stock right from TradingView charts — choose your broker and connect to your account.
LXEO reached its all-time high on Jan 18, 2024 with the price of 22.33 USD, and its all-time low was 9.00 USD and was reached on Nov 3, 2023. View more price dynamics on LXEO chart.
See other stocks reaching their highest and lowest prices.
As of May 7, 2024, the company has 58.00 employees. See our rating of the largest employees — is Lexeo Therapeutics, Inc. on this list?
We've gathered analysts' opinions on Lexeo Therapeutics, Inc. future price: according to them, LXEO price has a max estimate of 24.00 USD and a min estimate of 19.00 USD. Watch LXEO chart and read a more detailed Lexeo Therapeutics, Inc. stock forecast: see what analysts think of Lexeo Therapeutics, Inc. and suggest that you do with its stocks.